Screener
Sutro Biopharma STRO Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's net margin?
- Sutro Biopharma (STRO) reported net margin of -154.2% in Q1 2026.
- How has Sutro Biopharma's net margin changed year-over-year?
- Sutro Biopharma's net margin increased by 58.2% year-over-year, from -369.1% to -154.2%.
- What is the long-term trend for Sutro Biopharma's net margin?
- Over 4 years (2020 to 2025), Sutro Biopharma's net margin has grown at a 25.5% compound annual growth rate (CAGR), from -75.2% to -186.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Sutro Biopharma's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude